Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

Canada - TSX:ALS - CA0209361009 - Common Stock

30.91 CAD
+0.41 (+1.34%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

6

ALS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 795 industry peers in the Metals & Mining industry. ALS has an excellent profitability rating, but there are some minor concerns on its financial health. ALS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ALS was profitable.
ALS had a positive operating cash flow in the past year.
Of the past 5 years ALS 4 years were profitable.
ALS had a positive operating cash flow in each of the past 5 years.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

ALS has a Return On Assets of 13.83%. This is amongst the best in the industry. ALS outperforms 95.47% of its industry peers.
With an excellent Return On Equity value of 17.37%, ALS belongs to the best of the industry, outperforming 94.21% of the companies in the same industry.
The Return On Invested Capital of ALS (1.84%) is better than 89.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALS is significantly below the industry average of 11.87%.
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROIC 1.84%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ALS has a Profit Margin of 210.11%. This is amongst the best in the industry. ALS outperforms 99.12% of its industry peers.
ALS's Profit Margin has improved in the last couple of years.
The Operating Margin of ALS (41.65%) is better than 97.36% of its industry peers.
ALS's Operating Margin has been stable in the last couple of years.
The Gross Margin of ALS (88.04%) is better than 99.62% of its industry peers.
In the last couple of years the Gross Margin of ALS has remained more or less at the same level.
Industry RankSector Rank
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALS is destroying value.
The number of shares outstanding for ALS has been reduced compared to 1 year ago.
ALS has more shares outstanding than it did 5 years ago.
ALS has a worse debt/assets ratio than last year.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALS has an Altman-Z score of 6.17. This indicates that ALS is financially healthy and has little risk of bankruptcy at the moment.
ALS's Altman-Z score of 6.17 is fine compared to the rest of the industry. ALS outperforms 64.53% of its industry peers.
The Debt to FCF ratio of ALS is 5.08, which is a neutral value as it means it would take ALS, 5.08 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.08, ALS belongs to the top of the industry, outperforming 91.07% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that ALS is not too dependend on debt financing.
ALS has a Debt to Equity ratio of 0.16. This is in the lower half of the industry: ALS underperforms 67.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Altman-Z 6.17
ROIC/WACC0.2
WACC9.28%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 2.35 indicates that ALS has no problem at all paying its short term obligations.
ALS has a Current ratio (2.35) which is in line with its industry peers.
ALS has a Quick Ratio of 2.35. This indicates that ALS is financially healthy and has no problem in meeting its short term obligations.
ALS's Quick ratio of 2.35 is in line compared to the rest of the industry. ALS outperforms 58.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

3

3. Growth

3.1 Past

The earnings per share for ALS have decreased strongly by -29.63% in the last year.
Measured over the past years, ALS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.58% on average per year.
ALS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.35%.
The Revenue has been decreasing by -1.01% on average over the past years.
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%

3.2 Future

The Earnings Per Share is expected to grow by 24.80% on average over the next years. This is a very strong growth
ALS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.95% yearly.
EPS Next Y2.25%
EPS Next 2Y30.77%
EPS Next 3Y32.08%
EPS Next 5Y24.8%
Revenue Next Year-10.71%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 162.68 indicates a quite expensive valuation of ALS.
Based on the Price/Earnings ratio, ALS is valued cheaply inside the industry as 85.79% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.30. ALS is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 66.95, ALS can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALS is valued cheaper than 86.16% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. ALS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 162.68
Fwd PE 66.95
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALS is valued cheaper than 88.05% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 90.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 71.83
EV/EBITDA 59.49
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALS has an outstanding profitability rating, which may justify a higher PE ratio.
ALS's earnings are expected to grow with 32.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)72.44
PEG (5Y)N/A
EPS Next 2Y30.77%
EPS Next 3Y32.08%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.31%, ALS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 13.72, ALS pays a better dividend. On top of this ALS pays more dividend than 96.73% of the companies listed in the same industry.
With a Dividend Yield of 1.31, ALS pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

The dividend of ALS has a limited annual growth rate of 0.59%.
ALS has paid a dividend for at least 10 years, which is a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.59%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ALS pays out 15.18% of its income as dividend. This is a sustainable payout ratio.
ALS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP15.18%
EPS Next 2Y30.77%
EPS Next 3Y32.08%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (9/12/2025, 7:00:00 PM)

30.91

+0.41 (+1.34%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners19.64%
Inst Owner ChangeN/A
Ins Owners5.35%
Ins Owner ChangeN/A
Market Cap1.43B
Analysts78.18
Price Target36.43 (17.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.32
Dividend Growth(5Y)0.59%
DP15.18%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.51%
Min EPS beat(2)-29.28%
Max EPS beat(2)-25.74%
EPS beat(4)1
Avg EPS beat(4)-16.37%
Min EPS beat(4)-29.28%
Max EPS beat(4)18.81%
EPS beat(8)2
Avg EPS beat(8)-16.05%
EPS beat(12)2
Avg EPS beat(12)-23.29%
EPS beat(16)3
Avg EPS beat(16)-14.98%
Revenue beat(2)0
Avg Revenue beat(2)-14.07%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-5.33%
Revenue beat(4)0
Avg Revenue beat(4)-13.87%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)-5.33%
Revenue beat(8)2
Avg Revenue beat(8)-10.26%
Revenue beat(12)3
Avg Revenue beat(12)-7.39%
Revenue beat(16)5
Avg Revenue beat(16)-5.31%
PT rev (1m)5.49%
PT rev (3m)6.61%
EPS NQ rev (1m)-5.88%
EPS NQ rev (3m)-23.81%
EPS NY rev (1m)-11.83%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.56%
Revenue NY rev (1m)-0.73%
Revenue NY rev (3m)-4.94%
Valuation
Industry RankSector Rank
PE 162.68
Fwd PE 66.95
P/S 30.34
P/FCF 71.83
P/OCF 64.86
P/B 2.51
P/tB 2.51
EV/EBITDA 59.49
EPS(TTM)0.19
EY0.61%
EPS(NY)0.46
Fwd EY1.49%
FCF(TTM)0.43
FCFY1.39%
OCF(TTM)0.48
OCFY1.54%
SpS1.02
BVpS12.32
TBVpS12.32
PEG (NY)72.44
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROCE 2.78%
ROIC 1.84%
ROICexc 1.87%
ROICexgc 1.87%
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
FCFM 42.24%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ROICexc(3y)3.89%
ROICexc(5y)3.81%
ROICexgc(3y)3.89%
ROICexgc(5y)3.82%
ROCE(3y)5.26%
ROCE(5y)5.17%
ROICexcg growth 3Y-14.71%
ROICexcg growth 5Y-5.44%
ROICexc growth 3Y-14.71%
ROICexc growth 5Y-5.14%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Debt/EBITDA 3.69
Cap/Depr 38.31%
Cap/Sales 4.54%
Interest Coverage 2.43
Cash Conversion 87.43%
Profit Quality 20.1%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 6.17
F-Score5
WACC9.28%
ROIC/WACC0.2
Cap/Depr(3y)21.45%
Cap/Depr(5y)17.13%
Cap/Sales(3y)3.12%
Cap/Sales(5y)3.13%
Profit Quality(3y)194.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
EPS Next Y2.25%
EPS Next 2Y30.77%
EPS Next 3Y32.08%
EPS Next 5Y24.8%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%
Revenue Next Year-10.71%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%
EBIT growth 1Y-34.28%
EBIT growth 3Y-10.93%
EBIT growth 5Y0.32%
EBIT Next Year55.21%
EBIT Next 3Y28.31%
EBIT Next 5Y19.11%
FCF growth 1Y-67.12%
FCF growth 3Y-18.25%
FCF growth 5Y17.22%
OCF growth 1Y-64.63%
OCF growth 3Y-16.08%
OCF growth 5Y0.4%